FundingWatcher
Home / Startups / Top health care startups / Health care startups in Cambridge, Massachusetts

Health care startups in Cambridge, Massachusetts

Updated 16 Nov 2026

Reset
Health care startups in Cambridge, Massachusetts
One-time CSV
  • 354 funded companies, 304 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~cambridge-massachusetts.csv354 rows × 18 columns
CompanyCityLast roundAmountDate
Insilico MedicineCambridgeSeries E$123.0M2025-03-13
Iterative HealthCambridgeSeries C$77.0M2026-04-30
ConcertAICambridgeSeries C$150.0M2022-03-29
Biobot AnalyticsCambridgeSeries A$13.4M2025-06-06
Dyno TherapeuticsCambridgeSeries A$100.0M2021-05-06
basys.aiCambridgeSeed$25K2024-09-16
Cognito TherapeuticsCambridgeSeries C$105.0M2026-03-05
Terrestrial BioCambridgeSeries C$50.0M2026-03-26

8 rows of the CSV in 5 of its 18 columns.

354
Startups
$20.4B
Total raised
39
Funded in the last 12 months
$1.6B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

28 of 354
28 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
NeuroBionics NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. Biotech Seed $4.2M 2025-12-10 $9.2M MedTech Innovator, Dolby Family Ventures, GreyMatter +1 1 to 10 2023
Kano Therapeutics Kano Therapeutics develops single-stranded DNA for targeted gene correction. Biotech Seed $5.0M 2025-11-07 $7.1M Metaplanet, Taihill Venture, Vsquared Ventures +2 1 to 10 2021
Biobot Analytics Biobot Analytics offers a wastewater data platform that delivers population-level health insights. Artificial intelligence Series A $13.4M 2025-06-06 $41.4M Y Combinator, Pioneer Fund, Soma Capital +2 11 to 50 2017
Epicore Biosystems Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. Hardware Series B $6.0M 2025-05-01 $41.9M Alumni Ventures, National Institutes of Health, Joyance Partners +1 11 to 50 2017
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
Insilico Medicine Insilico Medicine develops an AI platform for drug development targeting cancer and age-related diseases. Artificial intelligence Series E $123.0M 2025-03-13 $624.3M Qiming Venture Partners, F-Prime, Warburg Pincus +1 101 to 250 2014
Convergent Therapeutics Convergent Therapeutics develops radiopharmaceutical therapies for prostate cancer. Health care Series A $40.0M 2024-09-24 $130.0M RA Capital Management, OrbiMed, Invus 1 to 10 2021
basys.ai Basys.ai automates prior authorization and utilization management for health plans using an AI-based platform. Artificial intelligence Seed $25K 2024-09-16 $2.4M Nina Capital, Asset Management Ventures (AMV), North South Ventures 1 to 10 2022
Cake Cake provides interactive tools and resources that use AI and data science to help consumers. Artificial intelligence Seed $125K 2024-07-11 $7.2M MassChallenge, OCA Ventures, GoAhead Ventures +1 1 to 10 2015
Nabla Bio Nabla Bio uses an autoverse platform of biologically informed machine learning to co-develop antibody drugs. Artificial intelligence Series A $26.0M 2024-05-14 $37.4M Y Combinator, Khosla Ventures, National Science Foundation +2 11 to 50 2020
Delphia Therapeutics Delphia Therapeutics operates a laboratory that develops treatments for cancer cells. Health care Series A $67.0M 2024-05-02 $67.0M Google Ventures, Polaris Partners, Alexandria Venture Investments +1 11 to 50 2022
NextPoint Therapeutics NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. Biotech Series B $42.5M 2024-02-14 $122.5M Invus, Leaps by Bayer, Catalio Capital Management +2 51 to 100 2020
Elemind Technologies Elemind Technologies develops neuromodulation techniques that shape brainwaves and change brain states. Biotech Seed $12.0M 2024-02-06 $12.0M Village Global, E14 Fund, Evolution VC Partners +2 11 to 50 2019
Nvelop Therapeutics Nvelop Therapeutics develops genetic medicines for patients with severe genetic diseases. Biotech Seed $100.0M 2023-09-20 $100.0M F-Prime, Atlas Venture, 5AM Ventures +1 51 to 100 2022
ROME Therapeutics ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. Biotech Series B $72.0M 2023-09-12 $199.0M Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 11 to 50 2020
Luminopia Luminopia develops digital treatments for significant neuro-visual disorders. Biotech Series A $16.0M 2023-06-27 $33.1M MassChallenge, U.S. Venture Partners, Bantam Group +2 11 to 50 2015
InsideTracker InsideTracker provides a platform that analyzes and tracks key biochemical and physiological markers. Biotech Series B $15.0M 2022-09-06 $18.2M OurCrowd, MassVentures, Puget Sound Venture Club +2 11 to 50 2009
Empatica Empatica develops affective computing technology and human data analytics. Artificial intelligence Series B $25.9M 2022-08-02 $35.6M Bossa Invest, Endeavor Catalyst, RA Capital Management +2 101 to 250 2011
ConcertAI Unicorn ConcertAI sells AI-powered SaaS data tools for medical research in oncology. Artificial intelligence Series C $150.0M 2022-03-29 $300.0M Maverick Ventures, Sixth Street, Declaration Partners +2 1,001 to 5,000 2018
Dyno Therapeutics Dyno Therapeutics uses artificial intelligence to develop gene therapies. Artificial intelligence Series A $100.0M 2021-05-06 $109.0M Andreessen Horowitz, Google Ventures, CRV +2 101 to 250 2018

Table 1. Health care startups in Cambridge, Massachusetts: the 28 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 354.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
2 Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
3 Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
4 Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
5 Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
6 UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
7 Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
8 NeuroBionics NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. Biotech Seed $4.2M 2025-12-10 $9.2M MedTech Innovator, Dolby Family Ventures, GreyMatter +1 1 to 10 2023
9 Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017

Table 2. Health care startups in Cambridge, Massachusetts: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 RA Capital Management Startup incubator Boston, United States 7 2% 1 Terrestrial Bio
2 F-Prime Venture capital firm Cambridge, United States 6 2% 1 Nocion Therapeutics
3 Alexandria Venture Investments Venture capital firm Pasadena, United States 5 1% 1 Kytopen
4 MassChallenge Startup accelerator Boston, United States 5 1%
5 Y Combinator Startup accelerator Mountain View, United States 4 1%
6 Google Ventures Corporate venture arm San Francisco, United States 4 1%
7 National Science Foundation Entrepreneurship program Alexandria, United States 4 1% 1 Kytopen
8 ARCH Venture Partners Venture capital firm Chicago, United States 4 1%
9 Alumni Ventures Angel group Manchester, United States 3 1% 1 Iterative Health
10 The Engine Venture capital firm Cambridge, United States 3 1% 2 Kytopen, Terrestrial Bio
11 Lux Capital Venture capital firm New York, United States 3 1% 1 Atavistik Bio
12 Andreessen Horowitz Venture capital firm Menlo Park, United States 3 1%
13 Polaris Partners Private equity firm Boston, United States 3 1%
14 Invus Private equity firm New York, United States 3 1%
15 MassVentures Venture capital firm Boston, United States 3 1% 1 Kytopen

Table 3. Health care startups in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 243 69% $18.7B
Software 74 21% $2.8B
Artificial intelligence 40 11% $2.4B
Hardware 17 5% $591.1M
Commerce 3 1% $4.5M
Fintech 2 1% $11.9M
Education 1 0% $4.0M
Cybersecurity 1 0% $1.1M
Energy 1 0%

Table 4. Health care startups in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 22 6% $325K
Seed 113 32% $1.8M
Series A 106 30% $31.0M
Series B 75 21% $42.5M
Series C 26 7% $73.9M
Series D+ 12 3% $48.0M

Table 5. Health care startups in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 3% $15.0M
October 2026 1 3% $150.0M
September 2026 3 8% $86.3M
August 2026 5 13% $262.5M
July 2026 1 3% $100K
June 2026 5 13% $270.5M
May 2026 2 5% $126.8M
April 2026 6 15% $233.6M
March 2026 7 18% $312.1M
February 2026 2 5% $1.4M
January 2026 4 10% $146.5M
December 2025 2 5% $4.2M

Table 6. Health care startups in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 37 10% $1.6B
2025 35 10% $1.6B
2024 29 8% $1.0B
2023 33 9% $1.8B
2022 38 11% $1.4B
2021 33 9% $1.7B

Table 7. Health care startups in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 29 8%
2020 to 2022 92 26%
2015 to 2019 120 34%
2010 to 2014 63 18%
Before 2010 46 13%

Table 8. Health care startups in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 123 35%
11 to 50 163 46%
51 to 100 39 11%
101 to 250 18 5%
251 to 500 3 1%
501 to 1,000 1 0%
1,001 to 5,000 2 1%
10,001 or more 2 1%

Table 9. Health care startups in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Cambridge, Massachusetts are on the list?
354, in the file dated 16 November 2026. 39 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 354 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in Cambridge, Massachusetts: 354 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care startups in Cambridge, Massachusetts by funding stage

Other sectors in Cambridge

Health care startups elsewhere

Cite: FundingWatcher, 354 funded health care companies in Cambridge, Massachusetts, 16 November 2026. https://fundingwatcher.com/startups/health-care/cambridge-massachusetts/